ClinicalTrialsFinder

Solitary Bone Plasmacytoma Clinical Trials in Tianjin

1 recruitingTianjin, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration

Plasma Cell DisordersSolitary Bone PlasmacytomaPlasmacytoma of Bone
Institute of Hematology & Blood Diseases Hospital, China21 enrolled1 locationNCT07115667